that activation of PPAR-γ is an interesting target for the disease. PPAR-γ is a transcription factor that is also expressed in chondrocytes. The aim of this study is to determine the effects of leptin and adiponectin on MMP-9 and MMP-13 secretion and PPAR-γ expression by chondrocytes. This study used chondrocyte cell line induced with IL-1β then exposed to leptin and adiponectin. MMP-9 and MMP-13 were measured using ELISA meanwhile PPAR-γ expression was measured by real time PCR. Leptin and adiponectin exposure increased MMP-9 and MMP-13 significantly, and in contrast they are also increased PPAR-γ expression in all groups. This results show that leptin and adiponectin have a role in the pathogenesis
Introduction
Osteoarthritis is the most common chronic musculoskeletal disorders and the most common form of arthritis. The disease is characterized by the breakdown of cartilage matrix, where chondrocytes is the only cell in cartilage responsible for the synthesis and degradation of cartilage matrix. In early osteoarthritis, chondrocytes induced by cytokines such as IL-1 and TNFα derived from synovial cells or macrophages. IL-1 is a potent pro-inflammatory cytokine which is able to stimulate chondrocytes to synthesize more IL-1 and other proinflammatory cytokines such as IL-6 and synthesize degradative enzymes MMP 1 .
IL-1 suppress the synthesis of type II collagen and proteoglycans, and inhibits proliferation of chondrocytes stimulated by transforming growth factor-β (TGF-β). Induction of IL-1 activates several transcription factors, such as NF-κB, AP-1, c-jun N-terminal kinase (JNK) and p38 MAPK. NFκB activation induces the transcription of several target genes involved in inflammation and the immune system, cell proliferation, cell cycle, and apoptosis. NFκB activation also induces several MMP genes, such as MMP-9 and MMP-13 2, 3, 4 .
Obesity is one of several risk factors of osteoarthritis. Adipose tissue, which is abundant in individuals with obesity, is an active endocrine organ that secretes cytokines and other molecules, including adipokines, such as leptin and adiponectin. Leptin, adiponectin, and their receptors have been identified in human chondrocytes. This hormone is associated with increased catabolic factors involved in the progression of osteoarthritis joints and cartilage destruction. Adiponectin seems to have a role as proinflammatory agents involved in joint cartilage matrix degradation. Therefore, leptin and adiponectin, considered to affect the pathogenesis of osteoarthritis 5, 6, 7 .
Until now, there is still no therapy to stop the progression of osteoarthritis. Recent studies suggest that activation of PPAR-γ (peroxisome proliferator-activated receptor gamma) is an interesting target for the disease.
PPAR-γ is a transcription factor that is also expressed in chondrocytes. Isoforms of PPAR-γ1 expression is decreased in osteoarthritis compared to normal cartilage. These findings suggest that the decreased expression of PPAR-γ in osteoarthritis cartilage reflects an increase in the expression of inflammatory and the catabolic factors 1 .
II. Material and Methods

Chondrocyte cell culture
Chondrocytes cell line were obtained from NHAC-Kn, Lonza. Cell line were thawed in Chondrocyte basal media supplemented with R3-IGF1, bFGF, transferrin, insulin, FBS, and gentamicin/amphotericin-B. Cells were then seeded in 25cm 2 flask at a density of 10.000 cells/cm 2 . The cells were incubated at 37 °C in a humidified atmosphere with 5% CO 2 , and the medium was changed once a week. The confluent cells were dispersed by trypsinization and were collected by centrifugation at 200g for 5 min. The cells were resuspended in alginate solution, aspirated into syringe, and released dropwise into 30ml polymerization solution. The cells will entrapped into alginate bead. Cells were fed every 2 to 3 days with differentiation media supplemented for 2 -3 weeks. At the end of incubation cells induced with IL-1β for 24 hours continued with exposure of leptin or adiponectin for 18 -24 hours.
RNA isolation and cDNA synthesis
Total RNA was extracted from confluent chondrocytes using TriReagent according to the manufacturer's procedures (Promega). RNA was recovered in DEPC-water and quantified by nanospectrophotometry at 260 and 280 nm. Then, RNA samples were reverse-transcribed to cDNA using GoScript TM Reverse transcription System (Promega, Cat. A5000). Experimental RNA, primer and nuclease-free water were mixed and centrifuged into RNA tube. The tube preheated into 70ºC then immediately chill in ice water for 5 minutes. The reverse transcription mix was prepared by combining the following component: reaction buffer, MgCl 2 , PCR nucleotide mix, reverse transcriptase, and nuclease-free water. The PCR conditions were as follows: annealing 25ºC for 5 minutes, 42ºC for 60 minutes, and 70ºC for 15 minutes. Then the tube immediately chilled on ice, and stored in -70ºC
Real Time PCR analysis
PPAR-γ expression levels were also determined by quantitative real-time RT-PCR using fluorescencelabeled (Light Cycler-Fast Start DNA Master SYBR Green I, Roche Applied Science) primers and LightCycler software (Roche Applied Science). The primers used were: PPAR-γ forward 5 -TGA CCA GGG AGT TCC TCA AAA -3 and PPAR-γ reverse 5 -AGC AAA CTC AAA CTT AGG CTC CAT -3; GAPDH forward 5 -CAG AAC ATC ATC CCT GCC TCT -3 and GAPDH reverse 5 -GCT TGA CAA AGT GGT CGT TGA -3. PCR conditions were: pre-incubation 95ºC 10 minutes 1 cycle; amplification 45 cycles of denaturation at 95ºC for 10 s, annealing at 56ºC for 20 s, and extension at 72ºC for 25 s; melting curve analysis 1 cycle of denaturation 95ºC 0 s, annealing 65ºC 15 s, melting 95ºC 0 s with slope 0,1ºC/s. Normalized gene expression was calculated as the ratio between PPAR-γ and glyceraldehyde-3-phosphate dehydrogenase copy number.
MMP measurement
The chondrocytes culture media was preserved for MMP-9 and MMP-13 measurement. MMP-9 were assayed using Elisa kit from R&D System, Inc. This assay employs the quantitative sandwich enzyme immunoasssay technique. A monoclonal antibody spesific for MMP-9 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells, and MMP-9 is bound by the immobilized antibody. After washing away unbound substances, an enzyme-linked polyclonal antibody spesific for MMP-9 is added to the wells. Following a wash to remove unbound antibody-enzyme reagent, a substrate solution is added to the wells and color development in proportion to the amount of MMP-9 bound in the initial step. The color development is stopped snd the intensity of the color is measured. MMP-13 were assayed in the conditioned culture media using ELISA kits from Abnova, cat no. KA0182 according to the manufacturer's protocol.
Statistical Analysis
B
Statistical analysis was performed with the Statistical Package for Social Sciences, v 16 (SPSS) using the appropriate parametric tests. The MMP-9, MMP-13, PPAR-γ level were measured and presented as mean ± SEM. The mean value was analysed by Kolmogorov Smirnov to determine the data distribution. The data distribution was normal (p > 0,05), then analysed by one way anova to determine the differences between groups. The differences in each groups analyzed using post hoc tukey test. The analysis of statistical correlation was performed by perason correlation test. A P value less than 0,05 was considered significant for the differences and correlation.
III. Result
The study was performed in Biomedic Laboratory, Physiology Laboratory, Parasitology Laboratory of Medical Faculty of Brawijaya University, Life Science Central Laboratory of Brawijaya University, and Science and Technology Laboratory of Islamic State University Maulana Malik Ibrahim Malang. This study used a chondrocyte cell line -Normal Human Articular Chondrocyte (Lonza), which is divided into 2 major groups: leptin group and adiponectin group, each group divided into 6 groups. Leptin group were: group 1, normal control; group 2, induced by IL-1β 10ng/ml; group 3, induced by IL-1β 10ng/ml and exposed to 100ng/ml leptin; group 4, induced by IL-1β 10ng/ml and exposed to leptin 1 μg / ml; group 5, induced by IL-1β 10ng/ml and exposed to leptin 10μg/ml; and group, induced by IL-1β 10ng/ml, leptin 10μg/ml and pioglitazone 10μM. Adiponectin group were : group 1, normal control; group 2, induced by IL-1β 10ng/ml; group 3, induced by IL-1β 10ng/ml and exposed to 100ng/ml adiponectin; group 4, induced by IL-1β 10ng/ml and exposed to adiponectin 1μg/ml; group 5, induced by IL-1β 10ng/ml and exposed to adiponectin 5μg/ml; and group 6, induced by IL-1β 10ng/ml, adiponectin 5μg/ml and pioglitazone 10μM. Cells used when reached confluency 70-80% then treated with alginate solution. The study was conducted from March to July 2014.
Figure 1. Effect of leptin in MMPs secretion by chondrocyte in various tratment groups. (A)
Leptin increased IL-1β-induced MMP-13 secretion on chondrocytes in dose dependent manner, significant effect seen in higher dose (leptin 1μg/ml and 10μg/ml). Addition of pioglitazone slightly decrease MMP-13 secretion. (B) Leptin increased IL-1β-induced-MMP-9 secretion also in dose dependent manner. Significant effect at leptin dose 10μg/ml, the pioglitazone addition decreased IL-1β-induced MMP-9 significantly. (1 : no treatment; 2 : chondrocyte induced by IL-1β 10ng/ml; 3 : chondrocyte induced by IL-1β 10ng/ml then treated with leptin 0,1μg/ml; 4 = chondrocyte induced by IL-1β 10ng/ml then treated with leptin 1μg/ml; 5 : chondrocyte induced by IL-1β 10ng/ml then treated with leptin 10μg/ml; 6 : chondrocyte induced by IL-1β 10ng/ml then treated with leptin 10μg/ml and pioglitazone 10μM). The histogram with error bars represents the mean and the standard error of the mean. Asterisks (*) denote a significant effect of increased MMP compared to normal (p < 0.05). Figure 1A showed that IL-1β increased MMP-13 secretion significantly. Addition of leptin also increased, significant effect found after L2 administration (p < 0,05). In the last group L3, pioglitazone was added to determine PPAR-γ pathway in increasing IL-1β-induced MMP-13 secretion. Our investigation showed no significant changes in IL-1β-induced MMP-13 secretion after pioglitazone addition (p = 0,447). Pioglitazone was one of the PPAR-γ ligands. A positive correlation was seen between leptin and MMP-13 secretion (R =
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0,927; p < 0,05). Figure 1B also revealed that leptin increased IL-1β-induced MMP-9 secretion, though the significant effect found in the highest dose of leptin. Addition of pioglitazone decreased IL-1β-induced MMP-9 secretion significantly (p = 0,018). Leptin and MMP-9 also have positive correlation (R = 0,870; p = 0,024). Figure 2A showed that adiponectin also increased MMP-13 secretion, but there was no significant changes after IL-1 induction (p = 0,651) and adiponectin 0,1μg/ml (p = 0,387) addition. Significant changes was seen after addition of adiponectin 1μg/ml. Pioglitazone addition decreased MMP-13 secretion significantly (p < 0,05). A positive correlation was seen between adiponectin and MMP-13 secretion (R = 0,943; p < 0,05). In Figure 2B IL-1 induction increased MMP-9 significantly (p < 0,05). Addition of adiponectin increased the secretion significantly at dose adiponectin 1μg/ml (p = 0,004) and dose adiponectin 5μg/ml (p = 0,006). A positive correlation was also seen between adiponectin and MMP-9 secretion (R = 0,788; p < 0,05).
Figure 2. Effect of adiponectin in MMPs secretion by chondrocyte in various tratment groups. (A)
Adiponectin increased IL-1β-induced MMP-13 secretion on chondrocytes in dose dependent manner, significant effect seen in higher dose (adiponectin 1μg/ml and 5μg/ml). Addition of pioglitazone decrease MMP-13 secretion significantly. (B) Adiponectin increased IL-1β-induced MMP-9 secretion also in dose dependent manner. Significant effect at leptin dose 10μg/ml, the pioglitazone addition decreased IL-1β-induced MMP-9 significantly. (a : no treatment; b : chondrocyte induced by IL-1β 10ng/ml; c : chondrocyte induced by IL-1β 10ng/ml then treated with adiponectin 0,1μg/ml; d = chondrocyte induced by IL-1β 10ng/ml then treated with adiponectin 1μg/ml; e : chondrocyte induced by IL-1β 10ng/ml then treated with adiponectin 5μg/ml; f : chondrocyte induced by IL-1β 10ng/ml then treated with adiponectin 5μg/ml and pioglitazone 10μM). The histogram with error bars represents the mean and the standard error of the mean. Asterisks (*) denote a significant effect of increased MMP compared to normal (p < 0.05).
PPAR-γ expression was measured by Real time PCR. Figure 3A 
IV. Discussion
Osteoarthritis is the most common joint disease and often accompanied by pain and joint dysfunction. The presence of cartilage destruction is an important factor onset of osteoarthritis. The articular cartilage damage is characterized by degeneration of the extracellular matrix (ECM). Enzymes that degrade the matrix, such as matrix metalloproteinase (MMP) plays an important role in this process because of its ability to damage type II collagen or aggrecans, which are two important components of ECM 8 . Changes in chondrocyte B A metabolism caused by the presence of proinflammatory mediators. The cytokines, mechanical trauma and genetic changes involved in the pathogenesis of osteoarthritis, and these factors may initiate the degenerative cascade that generates a lot of changes in the characteristics of articular cartilage in osteoarthritis. One of the pro-inflammatory cytokine that is a potent and play an important role on the pathogenesis of osteoarthritis is IL-1. IL-1 is able to induce chondrocytes to synthesize MMPs 9 . (1 : no treatment; 2: chondrocyte induced by IL-1β 10ng/ml; 3 : chondrocyte induced by IL-1β 10ng/ml then treated with leptin 0,1μg/ml; 4 = chondrocyte induced by IL-1β 10ng/ml then treated with leptin 1μg/ml; 5 : chondrocyte induced by IL-1β 10ng/ml then treated with leptin 10μg/ml; 6 : chondrocyte induced by IL-1β 10ng/ml then treated with leptin 10μg/ml and pioglitazone 10μM; a : normal; b : IL-1β 10ng/ml; c : chondrocyte induced by IL-1β 10ng/ml then treated with adiponectin 0,1μg/ml; d = chondrocyte induced by IL-1β 10ng/ml then treated with adiponectin 1μg/ml; e : chondrocyte induced by IL-1β 10ng/ml then treated with adiponectin 5μg/ml; f : chondrocyte induced by IL-1β 10ng/ml then treated with adiponectin 5μg/ml and pioglitazone 10μM). Asterisks (*) denote a significant effect of PPAR-γ expression compared to normal group (p < 0.05). The histogram with error bars represents the mean and the standard error of the mean.
This study revealed that induction of IL-1β increase the secretion of MMP-13 significantly. Induction of IL-1 activates several transcription factors, such as NF-κB, AP-1, c-jun N-terminal kinase (JNK) and p38 MAPK. The activation of NFκB induces several target genes transcription involved in the inflammation and immune system, cell proliferation, cell cycle, and apoptosis. Activation of NFκB also induces several MMP genes, such as MMP-3 and MMP-13 3, 4 .
Obesity is one of several risk factors of osteoarthritis. Obesity can increase the stiffness of collagen, mechanical changes of extracellular matrix, also can decrease the proteoglycans synthesis, where it may be become the beginning of cartilage degradation. Adipose tissue is able to secrete a hormone adipokines such as leptin, adiponectin, resistin and visfatin. Leptin, adiponectin and their receptors have been identified on the human chondrocytes. Leptin can increase catabolic factors, such as matrix metalloproteinase 10, 11 . This study showed that addition of leptin on IL-1β-induced chondrocytes increased the secretion of MMP-13 in a dosedependent manner. Leptin plays an important role in the pathophysiology of osteoarthritis. Leptin has powerful proinflamation effects 12 . Otero et al. showed that, in cultured human and murine chondrocytes, type 2 nitric oxide synthase (NOS2) and interferon-γ, and NOS2 activation by IL-1 β was increased by leptin via a mechanism that involved JAK2, PI3K, and mitogen-activated kinases (MEK1 and p38) 13 . Leptin also induced MMPs expression involved in osteoarthritis cartilage damage, such as MMP-9 and MMP-13. Other evidence also suggests that leptin alone and in combination with IL-1β is able to regulate the production of MMP-1 and MMP-3 in osteoarthritis cartilage through transcription factors NF-κB, protein kinase C, and MAP kinase pathways. In addition, administration of leptin can increase gene expression of ADAMTS-4 and -5 significantly and lowered proteoglican in cartilage 14 .
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Another adipokine is adiponectin. It has been found to improve insulin sensitivity and to have antiarthrogenic properties. Interestingly, adiponectin has also been identified as a regulatory factor in inflammation and arthritis. Tissues in the joint of OA patient including synovium, meniscus, osteophytes, cartilage, bone and fat, have been reported to produce adiponectin. In the present study adiponectin increased IL-1β-induced MMP-9 and MMP-13 significantly. In this study, we also found positive correlations between adiponectin and MMP-13 secretion and between adiponectin and MMP-9 secretion. This finding supports the role of adiponectin in cartilage degradation of OA cartilage. 15 The biological effects of adiponectin are mediated through two adiponectin receptor subtypes, adiponectin receptor type 1 (AdipoR1) and adiponectin receptor type 2 (AdipoR2) which have been shown to be expressed in articular cartilage. The AdipoR1-AMPK pathway could be associated with cartilage catabolism. Lago et al reported that the AMPK/Akt signaling pathway is involved in iNOS and MMP-3 induction by adiponectin in the murine chondrocyte ATDC5 cell line. While Kang et al reported that AMPK/JNK pathways are the major signaling pathway involved in adiponectinmediated induction of iNOS and MMPs in human OA chondrocytes, whereas the AMPK/Akt or AMPK/p38 pathway is partially involved in MMP-13 or MMP-3 induction, respectively 15, 16, 17 .
In this study, we also observed the expression of PPAR-γ. PPAR-γ activated by its agonist decreased the synthesis of catabolic response, inflammatory factors and reduce cartilage degradation in vivo and in vitro in osteoarthritis animal model. PPAR-γ is expressed in chondrocytes and the expression in osteoarthritis was decreased compared to normal cartilage. These findings suggest that the decreased expression of PPAR-γ in osteoarthritis cartilage reflect an increase of the inflammatory and catabolic factor expression 1, 18 . In this study, it was found that the addition of pioglitazone, as an activator of PPAR-γ, on leptin-treated chondrocyte slightly decreased the secretion of MMP-13. This suggests that leptin increased secretion of MMP-13 is influenced by the activation through many pathways. PPAR-γ interacts with other transcription factors and are not directly involved in binding to DNA to regulate gene transcription. For example, PPAR-γ have interaction with AP-1 (activator protein-1), STAT (signal transducers and activators of transcription), and NF-κB, which all transcription factors also play a role in regulation of gene expression. Proinflammatory transcription factor NF-κB has a central role in immune responses and inflammation, which is NF-κB is the main target of PPAR-γ to suppress inflammation 19 . In some studies, PPAR-γ was shown to interact with several co-activators such as cyclic adenosine monophosphate (cAMP)-responsive element binding factor (CREB)-binding protein (CBP), p300, steroid receptor co-activator-1 (SRC-1), and thyroid hormone receptor-associated protein (TRAP220). Some of the co-factors required for transcriptional activity of AP-1, NF-κB, Egr-1 (early growth response-1), STAT (signal transducers and activators of transcription), and NF-AT 20 .
Transactivation function of PPAR-γ is suppressed by IL-1 through NF-κB activated by the TAK1/TAB1/NF-κB-inducing kinase (NIK) cascade, a downstream cascade associated with IL-1 signalling 21 . Results in this study also showed that induction of IL-1β decreased the expression of PPAR-γ significantly and the addition of pioglitazone on IL-1β-induced chondrocytes was not able to increase the expression of PPAR-γ. Study by Mracek proved that administration of IL-1β inhibit brown adipocyte differentiation followed by a decrease in PPAR-γ mRNA levels 22 . In addition, research by Shan also explained that the PPAR-γ expression is regulated by IL-1β. In that study the induction of IL-1β may decrease the expression of PPAR-γ after 6 hours of induction 23 . In patients with osteoarthritis found that the expression of PPAR-γ decreased in the cartilage. The other studies have reported a that PPAR-γ expression decreased in mono-iodoacetate induced rat cartilage. These findings suggest that decreased expression of PPAR-γ in osteoarthritis cartilage will increase the gene expression of inflammatory and catabolic response, causing inflammation and degradation of articular cartilage. Effect of human osteoarthritis chondrocytes with IL-1β administration resulted in decreased expression of PPAR-γ 24 . Surprisingly, the other results in this study showed that leptin addition in low dose and intermediate dose was increased the expression of PPAR-γ, but addition in high dose of leptin start to decreased PPAR-γ expression. The finding that the addition of leptin only slightly decreased the expression of PPAR-γ at the mRNA level suggests that leptin may suppress the activity of PPAR-γ is also due to posttranslational modifications 25 . But on the other hand, study by Qian showed that leptin administration on adipose tissue increased PPAR-γ expression. Leptin administered via intracerebroventricular (ICV) induced adipose tissue apoptosis to determine its role in lipid metabolism. Expression of PPAR gamma in epididymal fat tissue was examined by Western immunoblot and in situ immunocytochemical analysis after 5 days of i.c.v. leptin treatment. Young and old rats (3 and 8 months old) were treated with or without 5 micrograms/d leptin. Leptin treatment increased PPAR gamma expression by 70-80% (P < 0.01) in both age groups. The study suggests that expression of PPAR gamma may be directly involved in the leptin-induced adipocyte apoptosis signal pathway 26 . Studies by Ajuwon showed that leptin in high dose decreased PPAR-γ expression in adipocyte. Two in vivo studies were conducted with pigs to determine the effects of exogenous leptin on the expression of peroxisome proliferator activated receptors (PPAR), and on serum concentrations of selected metabolites and hormones. Initially, leptin was administered i.m. to young pigs for 15 days at 0 (control), 0.003 (low), 0.01 (medium) and 0.03 (high) mg · kg -1 · day -1 . Leptin at the intermediate and high doses depressed adipose expression of both PPARγ1 (P < 0.06) and PPARγ2 (P < 0.01). The data presented here in indicate that leptin modulates lipid metabolism in the pig. And it varied in relation to dose in vivo 27 .
Other studies also demonstrate that leptin activates PPARs in C2C12 muscle cells. C2C12 pre-treated with AACOCF 3, a specific inhibitor of cytosolic phospsolipase A 2 (CPLA 2 ) , an enzyme that supplies ligands of PPARs. The result is leptin treatment significantly increased cPLA 2 activity. Furthermore, MEK1 inhibitor PD98059 showed that leptin activates cPLA 2 through ERK induction. These results support a direct effect of leptin on skeletal muscle cells, and suggest that the hormone may modulate muscle transcription also by precocious activation of PPARs through ERK-cPLA2 pathway 28 . High levels of leptin is not always associated with the destructive effect of the chondrocytes. The intra-articular injection of leptin can strongly stimulate the synthesis of insulin-like growth factor-1 (IGF-1) and transforming growth factor-β (TGF-β) at both the messenger RNA (mRNA) and protein levels which can exert anabolic activities in cartilage metabolism. Leptin concentrations in synovial fluid were also significantly correlated with BMI in people with severe osteoarthritis. These findings have suggested that high circulating leptin levels in obese individuals may protect cartilage from osteoarthritic degeneration 29 .
Our study also found that exposure of higher dose of adiponectin significantly increased PPAR-γ expression. Adiponectin is a fat-specific adipokine whose expression is tightly regulated by PPAR-γ, itself induces PPAR-γ 2 expression in a variety of cells. Transduction of the adiponectin signal by AdipoR1 and AdipoR2 involves the activation of AMP-activated protein kinase peroxisome proliferator activated receptors and seemingly other signal molecules 29, 30 . Increased PPAR-γ activity associated with increased adiponectin level 31 . But there are limited studies that correlate the level of adiponectin with increased PPAR-γ 1 expression. Present study demonstrate the first time that adiponectin stimulate PPAR-γ 1 expression in IL-1 induced chondrocytes. This result is linear to a study by Sagheb that showed that adiponectin significantly increased Pdx1 and PPAR-γ transcription and insulin secretion in rat islets 32 .
In addition to abundant expression in fat, PPAR-γ is detectable in wide range of cells. In light PPAR-γ's pleiotropic physiological roles, its relative abundance is predicted to have an important modulating influence on a variety of homeostatic responses. A large number of soluble mediators are known to effect PPAR-γ expression, stability and activity in a tissue and cell type-specific manner. Transcription factors shown to regulate PPAR-γ expression include C/EBPs, EBF proteins, inhibitor of DNA binding (ID) 2 and NF-E2 related factor 2 (Nrf2). Several cytokines and chemokines regulate PPAR-γ expression in mesenchymal cells. TGF-β is a potent inhibitor of PPAR-γ expression in fibroblasts and hepatic stellate cells. In contrast to fibroblasts, in monocytes and macrophages TGF-β stimulated PPAR-γ expression. The inflammatory cytokines TNF-α and IL-13 inhibit adipocyte differentiation by suppressing PPAR-γ expression 33 .
From the results it can be concluded that leptin and adiponectin increased MMP-9 and MMP-13 secretion, but this increase is not always followed by decreased of PPAR-γ expression. The regulation of PPAR-γ by adipokines seems complex in that it varied in relation to dose in vivo, and may be impacted by in vitro vs. in vivo circumstances. The increasing knowledge about the role of PPARs and adipokin in normal and osteoarthritis cartilage may help to decrease cartilage degradation.
V. Conclusion
Leptin and adiponectin could increase MMP-9 and MMP-13 secretion in IL-1β-induced chondrocyte. This results show that leptin and adiponectin have a role in pathogenesis of osteoarthritis by increasing catabolic response of chondrocyte. This study still needs further research using an animal model of osteoarthritis.
